Collaborations

Bright Minds engages with the broader scientific community to amplify our understanding of the biology and mechanism of action of mental and neurological disorders.

Leading experts in Epilepsy

Joseph Sullivan, MD

Pediatric neurologist, director of the UCSF Pediatric Epilepsy Center. One of the key leaders in Dravet Syndrome research

Dennis Dlugos, MD

Professor of neurology and pediatrics at Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania School of Medicine.

Jackie French, MD

Professor of Neurology in the Comprehensive Epilepsy Center at NYU Langone School of Medicine and Founder/Director of the Epilepsy Study Consortium

Roger J. Porter, MD

Adjunct Professor of Neurology at the Univ. of Pennsylvania and Adjunct Professor of Pharmacology at USUHS; he has served as Chief Scientific Officer of the Epilepsy Foundation

Terrence O’Brien, MD

Chair of Medicine, Monash University, and Deputy Director of Research, Alfred Health. Chair of The Australian Epilepsy Clinical Trial Network

Jo Sourbron, MD, PhD

Medical doctor at UZ Ghent. Research focus on novel serotonergic compounds for drug-resistant epilepsies

National Institutes of Health

Washington DC

 

Bright Minds is partnered with the NIH in two separate programs. One evaluating our compounds for the treatment of epilepsy. The other, assessing treatment for non-opioid pain management.

 

Acceptance into both programs is a strong validation for Bright Minds’ approach and existing data. This collaboration is an example of Bright Minds non-dilutive approach as associated costs are fully covered by the NIH.

University Of Texas Medical Branch

Cunningham Lab
Galveston, Texas

Led by Dr. Kathryn Cunningham PhD, the Cunningham Lab is a leader in the evaluation and development of therapeutics focused on addiction treatment and impulse control disorders such as binge eating.

Medical College of Wisconsin

McCorvy Lab
Milwaukee, Wisconsin

Led by Dr John McCorvy PhD, the McCorvy Lab is renown for its groundbreaking work on biological understanding of psychedelics and related compounds including the serotonergic system.

Katholieke Universiteit Leuven

DeWitte Lab

Leuven, Belgium

Led by Dr. Peter DeWitte PhD, the DeWitte Lab has been instrumental in furthering biological understanding of various epilepsy disorders including rare pediatric disorders such as Dravet Syndrome and Lennox-Gastaut Syndrome.